| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |